Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue SUPPL. 5, 2011, Pages 1-51

  Bonerandi, J J ^a   Beauvillain, C ^b   Caquant, L ^c   Chassagne, J F ^d   Chaussade, V ^e   Clavere P ^f   Desouches, C ^g   Garnier, F ^h   Grolleau, J L ⁱ   Grossin, M ^j   Jourdain, A ^k   Lemonnier, J Y ^l   Maillard, H ^m   Ortonne, N ⁿ   Rio, E ^o   Simon, E ^d   Sei, J F ^e   Grob, J J ^a   Martin, L ^p  

^a TIMONE HOSPITAL   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ JEAN MONNET   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e HÔPITAL AMBROISE PARÉ   (France)

^f LIMOGES UNIVERSITY HOSPITAL   (France)

^g Plastic Surgery   (France)

^h General Practitioner   (France)

ⁱ TOULOUSE UNIVERSITY HOSPITAL   (France)

^j HÔPITAL LOUIS MOURIER   (France)

^k ENT   (France)

^l Hospital Porte Madeleine   (France)

^m CENTRE HOSPITALIER DU MANS   (France)

ⁿ HENRI MONDOR HOSPITAL   (France)

^o Angers University Hospital ^*  (France)

^p ANGERS UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; BLEOMYCIN; CARBOPLATIN; CETUXIMAB; CISPLATIN; DICLOFENAC; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; IMIQUIMOD; METHOTREXATE; TAXANE DERIVATIVE;

ACTINIC KERATOSIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CLINICAL FEATURE; CRYOSURGERY; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; DISTANT METASTASIS; DRUG EFFICACY; DRUG WITHDRAWAL; HISTOPATHOLOGY; HUMAN; KERATOACANTHOMA; LYMPH NODE METASTASIS; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; TREATMENT PLANNING; TUMOR BIOPSY; UNSPECIFIED SIDE EFFECT; VERRUCOUS CARCINOMA;

CARCINOMA, SQUAMOUS CELL; HUMANS; PRACTICE GUIDELINES AS TOPIC; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS;

EID: 80955122762     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04296.x     Document Type: Article

References (198)

1. Anon. Carcinome épidermoïde cutané (carcinome spinocellulaire): recommandations de pratique clinique pour la prise en charge diagnostique et thérapeutique. Ann Dermatol Venereol 2009; 136 (Suppl. 5): S189-S242.
2. Fervers B, Burgers JS, Haugh MC, et al. Adaptation of clinical guidelines: literature review and proposition for a framework and procedure. Int J Qual Health Care 2006; 18: 167-176. (Pubitemid 43997301)
3. http://www.has-sante.fr/portail/jcms/c-531278/methode-et-processus- dadaptation-des-recommandations-pour-la-pratique-clinique-existantes.
4. http://www.has-sante.fr/portail/jcms/c-629812/suivi-am-bulatoire- deladulte-transplante-renal-au-dela-de-3-mois-apres-transplantation.
5. http://www.has-sante.fr/portail/jcms/c-430333/grille-de-valuation-de- laqualite-des-recommandations-pour-la-prati-que-clinique-traductionfrancaise-de- la-grille-agree-apprai-sal-of-guidelines-for-research-andevaluation-instrument
6. Brenn TM, McKee PH, Calonje JE, Lazar AJ,. Tumors of the surface epithelium. In Pathology of the Skin, Third edn. Elsevier, London, 2005: 1153-1240.
7. Non melanoma skin cancer: guidelines for treatment and management in Australia. Clinical practice guidelines. National Health Medical Research Council, Canberra, 2002.
8. Clinical practice guidelines in oncology. Basal cell and squamous cell skin cancers. National Comprehensive Cancer Network, Available at: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp (last accessed 12 October 2011)
9. Motley R, Kersey P, Lawrence C,. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2002; 146: 18-25. (Pubitemid 34158404)
10. de Berker D, McGregor JM, Hughes BR,. Guidelines for the management of actinic keratoses. Br J Dermatol 2007; 156: 222-230. (Pubitemid 46098882)
11. Cox NH, Eedy DJ, Morton CA,. Guidelines for management of Bowen's disease: 2006 update. Br J Dermatol 2007; 156: 11-21. (Pubitemid 44924139)
12. Freeman RG,. Carcinogenic effects of solar radiation and prevention measures. Cancer 1968; 21: 1114-1120.
13. Revenga Arranz F, Paricio Rubio JF, Mar Vazquez Salvado M, et al. Descriptive epidemiology of basal cell carcinoma and cutaneous squamous cell carcinoma in Soria (North-Eastern Spain) 1998-2000: a hospital-based survey. J Eur Acad Dermatol Venereol 2004; 18: 137-141. (Pubitemid 38379887)
14. Ziegler A, Jonason AS, Leffell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372: 773-776.
15. Bajdik CD, Gallagher RP, Astrakianakis G, et al. Non-solar ultraviolet radiation and the risk of basal and squamous cell skin cancer. Br J Cancer 1996; 73: 1612-1614. (Pubitemid 26235393)
16. Roest MA, Keane FM, Agnew K, et al. Multiple squamous skin carcinomas following excess sunbed use. J R Soc Med 2001; 94: 636-637. (Pubitemid 33151373)
17. Baudouin C, Charveron M, Tarroux R, Gall Y,. Environmental pollutants and skin cancer. Cell Biol Toxicol 2002; 18: 341-348. (Pubitemid 34984197)
18. Marks R, Staples M, Giles GG,. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer 1993; 53: 585-590. (Pubitemid 23069268)
19. Frost CA, Green AC,. Epidemiology of solar keratoses. Br J Dermatol 1994; 131: 455-464. (Pubitemid 24315411)
20. Harvey I, Frankel S, Marks R, et al. Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study. Br J Cancer 1996; 74: 1302-1307. (Pubitemid 26360124)
21. Memon AA, Tomenson JA, Bothwell J, Friedmann PS,. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 2000; 142: 1154-1159. (Pubitemid 30418302)
22. Marks R, Foley P, Goodman G, et al. Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol 1986; 115: 649-655. (Pubitemid 17181888)
23. Barr BB, Benton EC, McLaren K, et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989; 1: 124-129. (Pubitemid 19034033)
24. Dodson JM, DeSpain J, Hewett JE, Clark DP,. Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol 1991; 127: 1029-1031.
25. Cockerell CJ,. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000; 42: 11-17.
26. Cockerell CJ, Wharton JR,. New histopathological classification of actinic keratosis (incipient intraepidermal squamous cell carcinoma). J Drugs Dermatol 2005; 4: 462-467.
27. Cockerell CJ,. Pathology and pathobiology of the actinic (solar) keratosis. Br J Dermatol 2003; 149 (Suppl.66): 34-36. (Pubitemid 38064514)
28. Ortonne JP,. From actinic keratosis to squamous cell carcinoma. Br J Dermatol 2002; 146 (Suppl.61): 20-23.
29. Ackerman AB, Mones JM,. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol 2006; 155: 9-22. (Pubitemid 43876387)
30. Marks R, Rennie G, Selwood TS,. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; 1: 795-797. (Pubitemid 18094914)
31. Braakhuis BJ, Tabor MP, Kummer JA, et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63: 1727-1730. (Pubitemid 36460827)
32. Ulrich M, Maltusch A, Rowert-Huber J, et al. Actinic keratoses: non-invasive diagnosis for field cancerisation. Br J Dermatol 2007; 156 (Suppl.3): 13-17. (Pubitemid 46632516)
33. Vatve M, Ortonne JP, Birch-Machin MA, Gupta G,. Management of field change in actinic keratosis. Br J Dermatol 2007; 157 (Suppl.2): 21-24. (Pubitemid 350179625)
34. Kao GF,. Carcinoma arising in Bowen's disease. Arch Dermatol 1986; 122: 1124-1126. (Pubitemid 16022275)
35. Mora RG, Perniciaro C, Lee B,. Cancer of the skin in blacks. III. A review of nineteen black patients with Bowen's disease. J Am Acad Dermatol 1984; 11 (4 Pt 1): 557-562. (Pubitemid 14047262)
36. Grange F,. Épidémiologie des cancers cutanés en France. In, Guillot B, ed. Dépistage et cancers cutanés. Springer, Paris, 2008: 9-20.
37. Halna J, Grandadam M, Buemi A,. Étude épidé miologique des cancers cutanés basée sur la population d'un département français de 1998 Ã 1996: résultats du registre des cancers du Haut-Rhin. Nouv Dermatol 2000; 19: 48-55. (Pubitemid 32844605)
38. Bernard P, Derancourt C, Arnoult-Coudoux E, et al. [Skin cancer diagnosis by dermatologists in the region of Champagne-Ardenne: a prospective study]. Ann Dermatol Venereol 2001; 128: 883-887. (Pubitemid 32946332)
39. Nappi O, Pettinato G, Wick MR,. Adenoid (acantholytic) squamous cell carcinoma of the skin. J Cutan Pathol 1989; 16: 114-121. (Pubitemid 19181304)
40. Banks ER, Cooper PH,. Adenosquamous carcinoma of the skin: a report of 10 cases. J Cutan Pathol 1991; 18: 227-234.
41. Breuninger H, Schaumburg-Lever G, Holzschuh J, Horny HP,. Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer 1997; 79: 915-919. (Pubitemid 27089874)
42. LeBoit PE, Burg G, Weedon D, Sarasin A,. Pathology and Genetics of Skin Tumours. IARC Press, Lyon, 2006.
43. Weedon D,. Tumor of the epidermis. In, Weedon D,. ed. Skin Pathology, 2nd edn. Elsevier Science, London, 2002: 753-882.
44. Elder DE R, Jaworsky C, Johnson B,. Lever's Histopathology of the Skin, 8th edn. Lippincott Raven Press, New York, 1997.
45. Maguire B, Smith NP,. Histopathology of cutaneous squamous cell carcinoma. Clin Dermatol 1995; 13: 559-568. (Pubitemid 26101088)
46. Cassarino DS, Derienzo DP, Barr RJ,. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification-part two. J Cutan Pathol 2006; 33: 261-279.
47. Cassarino DS, Derienzo DP, Barr RJ,. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification-part one. J Cutan Pathol 2006; 33: 191-206.
48. Lohmann CM, Solomon AR,. Clinicopathologic variants of cutaneous squamous cell carcinoma. Adv Anat Pathol 2001; 8: 27-36.
49. Kane CL, Keehn CA, Smithberger E, Glass LF,. Histopathology of cutaneous squamous cell carcinoma and its variants. Semin Cutan Med Surg 2004; 23: 54-61. (Pubitemid 38402514)
50. Borel DM,. Cutaneous basosquamous carcinoma. Review of the literature and report of 35 cases. Arch Pathol 1973; 95: 293-297.
51. Martin RC, 2nd, Edwards MJ, Cawte TG, et al. Basosquamous carcinoma: analysis of prognostic factors in uencing recurrence. Cancer 2000; 88: 1365-1369. (Pubitemid 30155173)
52. Kraus FT, Perezmesa C,. Verrucous carcinoma. Clinical and pathologic study of 105 cases involving oral cavity, larynx and genitalia. Cancer 1966; 19: 26-38.
53. Klima M, Kurtis B, Jordan PH, Jr,. Verrucous carcinoma of skin. J Cutan Pathol 1980; 7: 88-98. (Pubitemid 10138638)
54. McKee PH, Wilkinson JD, Black MM, Whimster IW,. Carcinoma (epithelioma) cuniculatum: a clinico-pathological study of nine teen cases and review of the literature. Histopathology 1981; 5: 425-436. (Pubitemid 11012852)
55. Kao GF, Graham JH, Helwig EB,. Carcinoma cuniculatum (verrucous carcinoma of the skin): a clinicopathologic study of 46 cases with ultrastructural observations. Cancer 1982; 49: 2395-2403. (Pubitemid 12122930)
56. Banerjee SS, Eyden BP, Wells S, et al. Pseudoangiosarcomatous carcinoma: a clinicopathological study of seven cases. Histopathology 1992; 21: 13-23.
57. Johnson WC, Helwig EB,. Adenoid squamous cell carcinoma (adenoacanthoma). A clinicopathologic study of 155 patients. Cancer 1966; 19: 1639-1650.
58. Nappi O, Wick MR, Pettinato G, et al. Pseudovascular adenoid squamous cell carcinoma of the skin. A neoplasm that may be mistaken for angiosarcoma. Am J Surg Pathol 1992; 16: 429-438.
59. Evans HL, Smith JL,. Spindle cell squamous carcinomas and sarcoma-like tumors of the skin: a comparative study of 38 cases. Cancer 1980; 45: 2687-2697. (Pubitemid 10105329)
60. Lichtiger B, Mackay B, Tessmer CF,. Spindle-cell variant of squamous carcinoma. A light and electron microscopic study of 13 cases. Cancer 1970; 26: 1311-1320.
61. Smith KJ, Skelton HG, 3rd, Morgan AM, et al. Spindle cell neoplasms coexpressing cytokeratin and vimentin (metaplastic squamous cell carcinoma). J Cutan Pathol 1992; 19: 286-293.
62. Morgan MB, Lima-Maribona J, Miller RA, et al. Pigmented squamous cell carcinoma of the skin: morphologic and immunohistochemical study of five cases. J Cutan Pathol 2000; 27: 381-386. (Pubitemid 30488531)
63. Boscaino A, Terracciano LM, Donofrio V, et al. Tricholemmal carcinoma: a study of seven cases. J Cutan Pathol 1992; 19: 94-99.
64. Swanson PE, Marrogi AJ, Williams DJ, et al. Tricholemmal carcinoma: clinicopathologic study of 10 cases. J Cutan Pathol 1992; 19: 100-109.
65. Wong TY, Suster S,. Tricholemmal carcinoma. A clinicopathologic study of 13 cases. Am J Dermatopathol 1994; 16: 463-473. (Pubitemid 24323353)
66. Ferlicot S, Plantier F, Rethers L, et al. Lymphoepithelioma-like carcinoma of the skin: a report of 3 Epstein-Barr virus (EBV)-negative additional cases. Immunohistochemical study of the stroma reaction. J Cutan Pathol 2000; 27: 306-311. (Pubitemid 30389572)
67. Swanson SA, Cooper PH, Mills SE, Wick MR,. Lymphoepitheliomalike carcinoma of the skin. Mod Pathol 1988; 1: 359-365.
68. Kazakov DV, Nemcova J, Mikyskova I, Michal M,. Absence of Epstein-Barr virus, human papillomavirus, and simian virus 40 in patients of central European origin with lymphoepithelioma-like carcinoma of the skin. Am J Dermatopathol 2007; 29: 365-369. (Pubitemid 47220487)
69. Gillum PS, Morgan MB, Naylor MF, Everett MA,. Absence of Epstein-Barr virus in lymphoepitheliomalike carcinoma of the skin. Polymerase chain reaction evidence and review of five cases. Am J Dermatopathol 1996; 18: 478-482. (Pubitemid 26347268)
70. Cubilla AL, Reuter VE, Gregoire L, et al. Basaloid squamous cell carcinoma: a distinctive human papilloma virus-related penile neoplasm: a report of 20 cases. Am J Surg Pathol 1998; 22: 755-761. (Pubitemid 28280279)
71. Patel NK, McKee PH, Smith NP, Fletcher CD,. Primary meta-plastic carcinoma (carcinosarcoma) of the skin. A clinicopathologic study of four cases and review of the literature. Am J Dermatopathol 1997; 19: 363-372. (Pubitemid 27467162)
72. Azorin D, Rodriguez-Peralto JL, Garcia-Garcia E, Salamanca J,. Cutaneous papillary squamous cell carcinoma. Report of three new cases and review of the literature. Virchows Arch 2003; 442: 298-301. (Pubitemid 36399226)
73. Schwartz RA,. Verrucous carcinoma of the skin and mucosa. J Am Acad Dermatol 1995; 32: 1-21.
74. Bezerra AL, Lopes A, Landman G, et al. Clinicopathologic features and human papillomavirus DNA prevalence of warty and squamous cell carcinoma of the penis. Am J Surg Pathol 2001; 25: 673-678. (Pubitemid 32423368)
75. Martin F, Dalac S, Lambert D,. Carcinome verruqueux. Aspects nosologiques, Ã propos de 4 cas. Ann Dermatol Venereol 1995; 122: 399-403.
76. Azorin D, Lopez-Rios F, Ballestin C, et al. Primary cutaneous adenosquamous carcinoma: a case report and review of the literature. J Cutan Pathol 2001; 28: 542-545. (Pubitemid 33020618)
77. Dotto JE, Glusac EJ,. p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 2006; 33: 413-417. (Pubitemid 43865299)
78. Nagore E, Sanchez-Motilla JM, Perez-Valles A, MartinezLahuerta C, Alegre V, Aliaga A,. Pseudovascular squamous cell car cinoma of the skin. Clin Exp Dermatol 2000; 25: 206-208. (Pubitemid 30340548)
79. Ribeiro D, Narikawa S, Marques ME,. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin. Pathol Res Pract 2008; 204: 97-104.
80. Kuivanen TT, Jeskanen L, Kyllonen L, et al. Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas. Mod Pathol 2006; 19: 1203-1212. (Pubitemid 44268190)
81. Cribier B, Asch P, Grosshans E,. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases. Dermatology 1999; 199: 208-212.
82. Hodak E, Jones RE, Ackerman AB,. Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases. Am J Dermatopathol 1993; 15: 332-342.
83. Rowe DE, Carroll RJ, Day CL, Jr,. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992; 26: 976-990.
84. Petter G, Haustein UF,. Squamous cell carcinoma of the skinhistopathological features and their significance for the clinical outcome. J Eur Acad Dermatol Venereol 1998; 11: 37-44. (Pubitemid 28383613)
85. Moore BA, Weber RS, Prieto V, et al. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 2005; 115: 1561-1567. (Pubitemid 41330662)
86. Griffiths RW, Feeley K, Suvarna SK,. Audit of clinical and histological prognostic factors in primary invasive squamous cell carcinoma of the skin: assessment in a minimum 5 year follow-up study after conventional excisional surgery. Br J Plast Surg 2002; 55: 287-292. (Pubitemid 34830856)
87. Clayman GL, Lee JJ, Holsinger FC, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005; 23: 759-765. (Pubitemid 46237442)
88. Breuninger H, Black B, Rassner G,. Microstaging of squamous cell carcinomas. Am J Clin Pathol 1990; 94: 624-627. (Pubitemid 20369727)
89. Cherpelis BS, Marcusen C, Lang PG,. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 2002; 28: 268-273. (Pubitemid 34259756)
90. Mullen JT, Feng L, Xing Y, et al. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol 2006; 13: 902-909.
91. Friedman HI, Cooper PH, Wanebo HJ,. Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer 1985; 56: 1099-1105. (Pubitemid 15003494)
92. Dinehart SM, Pollack SV,. Metastases from squamous cell carcinoma of the skin and lip. An analysis of twenty-seven cases. J Am Acad Dermatol 1989; 21 (2 Pt 1): 241-248. (Pubitemid 19195886)
93. Nolan RC, Chan MT, Heenan PJ,. A clinicopathologic review of lethal nonmelanoma skin cancers in Western Australia. J Am Acad Dermatol 2005; 52: 101-108. (Pubitemid 40038941)
94. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS,. Incidence of skin cancer in 5,356 patients following organ transplantation. Br J Dermatol 2000; 143: 513-519.
95. Jensen P, Moller B, Hansen S,. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 2000; 42 (2 Pt 1): 307. (Pubitemid 30469641)
96. Ong CS, Keogh AM, Kossard S, et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40: 27-34. (Pubitemid 29051021)
97. Harwood CA, Proby CM, McGregor JM, et al. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006; 54: 290-300. (Pubitemid 43144399)
98. Leibovitch I, Huilgol SC, Selva D, et al. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. J Am Acad Dermatol 2005; 53: 458-463. (Pubitemid 41195968)
99. Goepfert H, Dichtel WJ, Medina JE, et al. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg 1984; 148: 542-547.
100. O'Brien CJ, McNeil EB, McMahon JD, et al. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 2002; 24: 417-422. (Pubitemid 34506700)
101. Trakatelli M, Ulrich C, del Marmol V, et al. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 2007; 156 (Suppl.3): 1-7. (Pubitemid 46646534)
102. Norris JF,. Sunscreens, suntans, and skin cancer. Local councils should remove sunbeds from leisure centres. BMJ 1996; 313: 941-942.
103. van der Pols JC, Williams GM, Pandeya N, et al. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 2006; 15: 2546-2548. (Pubitemid 46048320)
104. Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photo-dynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007; 56: 125-143. (Pubitemid 44969292)
105. Stockfleth E, Kerl H,. Guidelines for the management of actinic keratoses. Eur J Dermatol 2006; 16: 599-606.
106. Chen K, Yap LM, Marks R, Shumack S,. Short-course therapy with imiquimod 5% cream for solar keratoses: a randomized controlled trial. Australas J Dermatol 2003; 44: 250-255. (Pubitemid 37518550)
107. Lebwohl M, Dinehart S, Whiting D, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol 2004; 50: 714-721. (Pubitemid 38580548)
108. Korman N, Moy R, Ling M, et al. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Arch Dermatol 2005; 141: 467-473. (Pubitemid 40547405)
109. Stock Fleth E, Sterry W, Carey-Yard M, Bichel J,. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head. Br J Dermatol 2007; 157 (Suppl.2): 41-46. (Pubitemid 350179629)
110. Alomar A, Bichel J, McRae S,. Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head. Br J Dermatol 2007; 157: 133-141. (Pubitemid 46934262)
111. Jorizzo J, Dinehart S, Matheson R, et al. Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head. J Am Acad Dermatol 2007; 57: 265-268. (Pubitemid 47048863)
112. Krawtchenko N, Roewert-Huber J, Ulrich M, et al. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol 2007; 157 (Suppl.2): 34-40. (Pubitemid 350179628)
113. Rivers JK, Arlette J, Shear N, et al. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol 2002; 146: 94-100. (Pubitemid 34158414)
114. Gebauer K, Brown P, Varigos G,. Topical diclofenac in hyaluronan gel for the treatment of solar keratoses. Australas J Dermatol 2003; 44: 40-43. (Pubitemid 36246421)
115. Wolf JE, Jr,., Taylor JR, Tschen E, Kang S,. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 2001; 40: 709-713. (Pubitemid 34023642)
116. Fariba I, Ali A, Hossein SA, et al. Efficacy of 3% diclofenac gel for the treatment of actinic keratoses: a randomized, double-blind, placebo controlled study. Indian J Dermatol Venereol Leprol 2006; 72: 346-349. (Pubitemid 44579162)
117. Smith SR, Morhenn VB, Piacquadio DJ,. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp. J Drugs Dermatol 2006; 5: 156-159.
118. Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-uorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 1999; 41 (3 Pt 1): 414-418. (Pubitemid 29418508)
119. Morton C, Campbell S, Gupta G, et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 2006; 155: 1029-1036. (Pubitemid 44564515)
120. Sherry SD, Miles BA, Finn RA,. Long-term efficacy of carbon dioxide laser resurfacing for facial actinic keratosis. J Oral Maxillofac Surg 2007; 65: 1135-1139. (Pubitemid 46778941)
121. Bargman H, Hochman J,. Topical treatment of Bowen's disease with 5-fluorouracil. J Cutan Med Surg 2003; 7: 101-105. (Pubitemid 36506157)
122. Mackenzie-Wood A, Kossard S, de Launey J, et al. Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol 2001; 44: 462-470. (Pubitemid 32199966)
123. Morton CA, Whitehurst C, Moseley H, et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 1996; 135: 766-771. (Pubitemid 26375895)
124. Ahmed I, Berth-Jones J, Charles-Holmes S, et al. Comparison of cryotherapy with curettage in the treatment of Bowen's disease: a prospective study. Br J Dermatol 2000; 143: 759-766.
125. Brodland DG, Zitelli JA,. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992; 27 (2 Pt 1): 241-248.
126. Albright SD, 3rd,. Treatment of skin cancer using multiple modalities. J Am Acad Dermatol 1982; 7: 143-171.
127. Freeman RG, Knox JM, Heaton CL,. The treatment of skin cancer. A statistical study of 1,341 skin tumors comparing results obtained with irradiation, surgery, and curettage followed by electrodesiccation. Cancer 1964; 17: 535-538.
128. Ghauri RR, Gunter AA, Weber RA,. Frozen section analysis in the management of skin cancers. Ann Plast Surg 1999; 43: 156-160. (Pubitemid 29380015)
129. Mohs FE,. A microscopically controlled method of cancer excision. Arch Surg 1941; 44: 279-295.
130. Rapini RP,. Comparison of methods for checking surgical margins. J Am Acad Dermatol 1990; 23 (2 Pt 1): 288-294. (Pubitemid 20259925)
131. Leibovitch I, Huilgol SC, Selva D, et al. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol 2005; 53: 253-260. (Pubitemid 40979582)
132. Malhotra R, Huilgol SC, Huynh NT, Selva D,. The Australian Mohs database: periocular squamous cell carcinoma. Ophthalmology 2004; 111: 617-623. (Pubitemid 38429657)
133. Sei JF, Chaussade V, Zimmermann U, et al. Historique, principes, analyse critique de l'efficacité et indications de la chirurgie micrographique de Mohs. Ann Dermatol Venereol 2004; 131: 173-182. (Pubitemid 38339194)
134. Frierson HF, Jr,., Cooper PH,. Prognostic factors in squamous cell carcinoma of the lower lip. Hum Pathol 1986; 17: 346-354. (Pubitemid 16018571)
135. Martinez JC, Cook JL,. High-risk cutaneous squamous cell carcinoma without palpable lymphadenopathy: is there a therapeutic role for elective neck dissection? Dermatol Surg 2007; 33: 410-420. (Pubitemid 46570111)
136. Miller SJ, Alam M, Andersen J, et al. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw 2007; 5: 506-529. (Pubitemid 46815212)
137. Stoeckli SJ, Steinert H, Pfaltz M, Schmid S,. Sentinel lymph node evaluation in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 2001; 125: 221-226. (Pubitemid 33662671)
138. Caccialanza M, Piccinno R, Moretti D, Rozza M,. Radiotherapy of carcinomas of the skin overlying the cartilage of the nose: results in 405 lesions. Eur J Dermatol 2003; 13: 462-465. (Pubitemid 37309306)
139. Hernandez-Machin B, Borrego L, Gil-Garcia M, Hernandez BH,. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments. Int J Dermatol 2007; 46: 453-459. (Pubitemid 46711421)
140. Silva JJ, Tsang RW, Panzarella T, et al. Results of radiotherapy for epithelial skin cancer of the pinna: the Princess Margaret Hospital experience, 1982-1993. Int J Radiat Oncol Biol Phys 2000; 47: 451-459. (Pubitemid 30236388)
141. Tsao MN, Tsang RW, Liu FF, et al. Radiotherapy management for squamous cell carcinoma of the nasal skin: the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys 2002; 52: 973-979. (Pubitemid 34219016)
142. Baris G, Visser AG, van Andel JG,. The treatment of squamous cell carcinoma of the nasal vestibule with interstitial iridium implantation. Radiother Oncol 1985; 4: 121-125. (Pubitemid 15242652)
143. Beauvois S, Hoffstetter S, Peiffert D, et al. Brachytherapy for lower lip epidermoid cancer: tumoral and treatment factors influencing recurrences and complications. Radiother Oncol 1994; 33: 195-203.
144. Conill C, Verger E, Marruecos J, et al. Low dose rate brachytherapy in lip carcinoma. Clin Transl Oncol 2007; 9: 251-254.
145. Crook JM, Jezioranski J, Grimard L, et al. Penile brachytherapy: results for 49 patients. Int J Radiat Oncol Biol Phys 2005; 62: 460-467. (Pubitemid 40704463)
146. Crook JM, Mazeron JJ, Marinello G, et al. Interstitial iridium 192 for cutaneous carcinoma of the external nose. Int J Radiat Oncol Biol Phys 1990; 18: 243-248. (Pubitemid 20047413)
147. Daly NJ, de Lafontan B, Combes PF,. Results of the treatment of 165 lid carcinomas by iridium wire implant. Int J Radiat Oncol Biol Phys 1984; 10: 455-459. (Pubitemid 14111277)
148. de Visscher JG, Grond AJ, Botke G, van der Waal I,. Results of radiotherapy for squamous cell carcinoma of the vermilion border of the lower lip. A retrospective analysis of 108 patients. Radiother Oncol 1996; 39: 9-14. (Pubitemid 26135602)
149. Delannes M, Malavaud B, Douchez J, et al. Iridium-192 interstitial therapy for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 1992; 24: 479-483.
150. Guinot JL, Arribas L, Chust ML, et al. Lip cancer treatment with high dose rate brachytherapy. Radiother Oncol 2003; 69: 113-115. (Pubitemid 37346195)
151. Levendag PC, Pomp J,. Radiation therapy of squamous cell carcinoma of the nasal vestibule. Int J Radiat Oncol Biol Phys 1990; 19: 1363-1367.
152. Mazeron JJ, Ghalie R, Zeller J, et al. Radiation therapy for carcinoma of the pinna using iridium 192 wires: a series of 70 patients. Int J Radiat Oncol Biol Phys 1986; 12: 1757-1763. (Pubitemid 17182214)
153. Mazeron JJ, Richaud P,. [Results of ionizing radiation treatment of 2,274 epidermoid epitheliomas of the lips]. Rev Stomatol Chir Maxillofac 1983; 84: 305-306. (Pubitemid 14238386)
154. Pigneux J, Richaud PM, Lagarde C,. The place of interstitial therapy using 192 iridium in the management of carcinoma of the lip. Cancer 1979; 43: 1073-1077. (Pubitemid 9165424)
155. Han A, Ratner D,. What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion? Cancer 2007; 109: 1053-1059. (Pubitemid 46435382)
156. Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer 2006; 106: 1078-1083.
157. Chen AM, Grekin RC, Garcia J, et al. Radiation therapy for cutaneous squamous cell carcinoma involving the parotid area lymph nodes: dose and volume considerations. Int J Radiat Oncol Biol Phys 2007; 69: 1377-1380. (Pubitemid 350116397)
158. Geohas J, Roholt NS, Robinson JK,. Adjuvant radiotherapy after excision of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1994; 30: 633-636. (Pubitemid 24121766)
159. Jol JA, van Velthuysen ML, Hilgers FJ, et al. Treatment results of regional metastasis from cutaneous head and neck squamous cell carcinoma. Eur J Surg Oncol 2003; 29: 81-86. (Pubitemid 36181783)
160. Veness MJ, Palme CE, Morgan GJ,. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer 2006; 106: 2389-2396. (Pubitemid 43787663)
161. Veness MJ, Porceddu S, Palme CE, Morgan GJ,. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 2007; 29: 621-631. (Pubitemid 47168232)
162. Argiris A, Karamouzis MV, Raben D, Ferris RL,. Head and neck cancer. Lancet 2008; 371: 1695-1709. (Pubitemid 351671886)
163. Khansur T, Kennedy A,. Cisplatin and 5-uorouracil for advanced locoregional and metastatic squamous cell carcinoma of the skin. Cancer 1991; 67: 2030-2032.
164. Sadek H, Azli N, Wendling JL, et al. Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin. Cancer 1990; 66: 1692-1696. (Pubitemid 20381201)
165. Olieman AF, Lienard D, Eggermont AM, et al. Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study. Arch Surg 1999; 134: 303-307. (Pubitemid 29136017)
166. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945-1952. (Pubitemid 38580197)
167. Pignon JP, Bourhis J, Domenge C, Designe L,. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000; 355: 949-955. (Pubitemid 30148259)
168. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91: 2081-2086. (Pubitemid 30019568)
169. Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000; 18: 1458-1464. (Pubitemid 30205391)
170. Burtness B, Goldwasser MA, Flood W, et al. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol 2005; 23: 8646-8654. (Pubitemid 46211507)
171. Bauman JE, Eaton KD, Martins RG,. Treatment of recurrent squamous cell carcinoma of the skin with cetuximab. Arch Dermatol 2007; 143: 889-892. (Pubitemid 47076487)
172. Maclean GM, Coleman DJ,. Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa. Ann R Coll Surg Engl 2007; 89: 709-712. (Pubitemid 47577786)
173. Wechsler J, Verola O, Vergier B,. [Monitoring of the margins of excision of skin tumors]. Ann Pathol 1997; 17: 67-71. (Pubitemid 27160240)
174. Moehrle M, Breuninger H, Taieb A, et al. Histologie 3D: une technique de chirurgie micrographique adaptée aux dermatologues et pathologistes hospitaliers et libéraux. Ann Dermatol Venereol 2007; 134: 87-93. (Pubitemid 46197107)
175. Khanna M, Fortier-Riberdy G, Dinehart SM, Smoller B,. Histopathologic evaluation of cutaneous squamous cell carcinoma: results of a survey among dermatopathologists. J Am Acad Dermatol 2003; 48: 721-726. (Pubitemid 36583283)
176. Tavin E, Persky M,. Metastatic cutaneous squamous cell carcinoma of the head and neck region. Laryngoscope 1996; 106 (2 Pt 1): 156-158. (Pubitemid 26052770)
177. Friedman M, Mafee MF, Pacella BL, Jr,. et al. Rationale for elective neck dissection in 1990. Laryngoscope 1990; 100: 54-59. (Pubitemid 20020498)
178. Krishna RP, Sistla SC, Smile R, Krishnan R,. Sonography: an underutilized diagnostic tool in the assessment of metastatic groin nodes. J Clin Ultrasound 2008; 36: 212-217. (Pubitemid 351537000)
179. Sumi M, Ohki M, Nakamura T,. Comparison of sonography and CT for differentiating benign from malignant cervical lymph nodes in patients with squamous cell carcinoma of the head and neck. Am J Roentgenol 2001; 176: 1019-1024. (Pubitemid 32240957)
180. Richards PS, Peacock TE,. The role of ultrasound in the detection of cervical lymph node metastases in clinically N0 squamous cell carcinoma of the head and neck. Cancer Imaging 2007; 7: 167-178.
181. Akoglu E, Dutipek M, Bekis R, et al. Assessment of cervical lymph node metastasis with different imaging methods in patients with head and neck squamous cell carcinoma. J Otolaryngol 2005; 34: 384-394. (Pubitemid 43111256)
182. Juweid ME, Cheson BD,. Positron-emission tomography and assessment of cancer therapy. N Engl J Med 2006; 354: 496-507. (Pubitemid 43200300)
183. Yousem DM, Som PM, Hackney DB, et al. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology 1992; 182: 753-759.
184. Ginsberg LE,. MR imaging of perineural tumor spread. Magn Reson Imaging Clin N Am 2002; 10: 511-525. (Pubitemid 35253660)
185. Bailet JW, Abemayor E, Jabour BA, et al. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992; 102: 281-288.
186. Ross AS, Schmults CD,. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg 2006; 32: 1309-1321. (Pubitemid 44691132)
187. Renzi C, Caggiati A, Mannooranparampil TJ, et al. Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature. Eur J Surg Oncol 2007; 33: 364-369. (Pubitemid 46488665)
188. Chaïbi P, Tagzirt M, Piette F,. L'évaluation gérontologique des patients âgés atteints d'affections malignes: une démarche graduée. Oncologie 2007; 9: 181-265.
189. Rodde Dunet MH, Vitoux A,. [Development of geriatric oncology within the framework of the cancer plan]. Med Sci (Paris) 2007; 23: 47-51. (Pubitemid 350003954)
190. Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005; 55: 241-252. (Pubitemid 41219694)
191. Monfardini S, Ferrucci L, Fratino L, et al. Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer 1996; 77: 395-401. (Pubitemid 26023359)
192. Balducci L, Extermann M,. Management of cancer in the older person: a practical approach. Oncologist 2000; 5: 224-237. (Pubitemid 30429942)
193. McGuirt WF, McCabe BF,. Significance of node biopsy before definitive treatment of cervical metastatic carcinoma. Laryngoscope 1978; 88: 594-597.
194. Richard MA, Gachon J, Choux R, et al. Traitement des ké ratoacanthomes par injections intralésionnelles de méthotrexate. Ann Dermatol Venereol 2000; 127: 1097.
195. Annest NM, VanBeek MJ, Arpey CJ, Whitaker DC,. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature. J Am Acad Dermatol 2007; 56: 989-993. (Pubitemid 46720214)
196. Heid E,. Kératoacanthomes. Nouvelles possibilités thérapeuthiques. Ann Dermatol Venereol 1987; 114: 407-408.
197. Goette DK, Odom RB,. Successful treatment of keratoacanthoma with intralesional fluorouracil. J Am Acad Dermatol 1980; 2: 212-216.
198. Grob JJ, Suzini F, Richard MA, et al. Large keratoacanthomas treated with intralesional interferon alfa-2a. J Am Acad Dermatol 1993; 29 (2 Pt 1): 237-241. (Pubitemid 23221904)